KemPharm (KMPH)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Travis C. Mickle
Employees:
33
2500 CROSSPARK ROAD, SUITE E126, CORALVILLE, IA 52241
319-665-2575

KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. Its portfolio of product addresses pain, attention-deficit or hyperactivity disorder, and central nervous system. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Coralville, IA.

Data derived from most recent annual or quarterly report
Market Cap 282.555 Million Shares Outstanding35.319 Million Avg 30-day Volume 448.128 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.94
Price to Revenue0.0 Debt to Equity0.0 EBITDA0
Price to Book Value0.0 Operating Margin0.0 Enterprise Value197.081 Million
Current Ratio36.406 EPS Growth0 Quick Ratio35.998
1 Yr BETA 2.5285 52-week High/Low 18.15 / 5.85 Profit Margin0.0
Operating Cash Flow Growth0.0 Altman Z-Score0.0 Free Cash Flow to Firm 0
View SEC Filings from KMPH instead.

View recent insider trading info

Funds Holding KMPH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding KMPH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

3.5 Thousand total shares from 2 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PLOOSTER MATTHEW R

  • Director
4,101 2021-12-01 2

TIERNEY DAVID S

  • Director
3,835 2021-11-30 2

PASCOE RICHARD W EXECUTIVE CHAIRMAN

  • Officer
  • Director
3,285 2021-11-30 3

CLIFTON R. LADUANE CFO, SECRETARY & TREASURER

  • Officer
5,240 2021-11-18 7

MICKLE TRAVIS C PRESIDENT & CEO

  • Officer
  • Director
158,774 2021-11-18 4

GUENTHER SVEN EVP, RESEARCH & DEVELOPMENT

  • Officer
81,716 2021-08-20 1

SANGIOVANNI TIMOTHY J. VP, CORPORATE CONTROLLER

  • Officer
44,023 2021-08-20 1

SEYMOUR TAMARA A

  • Director
0 2021-08-18 1

SALURI JOSEPH

  • Director
15,000 2021-06-17 1

BRAUN SAMUEL J

  • 10% Owner
3,070,000 2021-05-13 2

JOHNSON GORDON K CHIEF BUSINESS OFFICER

  • Officer
40,000 2019-12-31 0

THOMPSON DANNY L

  • Director
130,787 2019-06-30 0

DELAWARE STREET CAPITAL MASTER FUND, L.P.

DSC ADVISORS, L.P.

DSC MANAGERS, L.L.C.

DSC ADVISORS, L.L.C.

BLUHM ANDREW G

  • 10% Owner
4,095,914 2018-10-05 0

COHEN DANIEL L EVP, GOVT. & PUBLIC RELATIONS

  • Officer
40,400 2018-05-15 0

MICKLE CHRISTAL M M VP, OPERATIONS & PRODUCT DVLP.

  • Officer
  • 10% Owner
2,387,145 2017-03-22 0

WOODY TRACY M CHIEF COMMERCIAL OFFICER

  • Officer
0 2016-02-11 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

PLOOSTER MATTHEW R - Director

2021-12-01 16:28:32 -0500 2021-12-01 A 2,500 $8.44 a 2,500 direct -6.0827 5.5961 -0.365 13.2603 17 -7.5426 11

TIERNEY DAVID S - Director

2021-11-30 16:10:31 -0500 2021-11-30 P 2,000 $7.79 a 3,835 direct 2.3661 9.2154 1.4944 15.9402 18 -5.3549 12

PASCOE RICHARD W - Director - Officer EXECUTIVE CHAIRMAN

2021-11-30 19:42:19 -0500 2021-11-30 P 1,500 $7.88 a 3,285 direct 2.3661 9.2154 1.4944 15.9402 18 -5.3549 12

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
KEMPHARM INC KMPH 2022-01-19 22:15:03 UTC -2.5308 2.6008 1500000
KEMPHARM INC KMPH 2022-01-19 21:45:03 UTC -2.5308 2.6008 1500000
KEMPHARM INC KMPH 2022-01-19 21:15:04 UTC -2.5308 2.6008 1500000
KEMPHARM INC KMPH 2022-01-19 20:45:03 UTC -2.5308 2.6008 1500000
KEMPHARM INC KMPH 2022-01-19 20:15:03 UTC -2.5308 2.6008 1500000
KEMPHARM INC KMPH 2022-01-19 19:45:03 UTC -2.5308 2.6008 1500000
KEMPHARM INC KMPH 2022-01-19 19:15:03 UTC -2.5308 2.6008 1500000
KEMPHARM INC KMPH 2022-01-19 18:45:03 UTC -2.5308 2.6008 1500000
KEMPHARM INC KMPH 2022-01-19 18:15:03 UTC -2.5308 2.6008 1500000
KEMPHARM INC KMPH 2022-01-19 17:45:03 UTC -2.5308 2.6008 1500000
KEMPHARM INC KMPH 2022-01-19 17:15:04 UTC -2.5308 2.6008 1500000
KEMPHARM INC KMPH 2022-01-19 16:45:03 UTC -2.5513 2.6213 1500000
KEMPHARM INC KMPH 2022-01-19 16:15:03 UTC -2.5513 2.6213 1500000
KEMPHARM INC KMPH 2022-01-19 15:45:03 UTC -2.5513 2.6213 1500000
KEMPHARM INC KMPH 2022-01-19 15:15:03 UTC -2.5513 2.6213 1500000
KEMPHARM INC KMPH 2022-01-19 14:45:03 UTC -3.9851 4.0551 1500000
KEMPHARM INC KMPH 2022-01-19 14:15:03 UTC -3.9851 4.0551 1500000
KEMPHARM INC KMPH 2022-01-19 13:45:03 UTC -3.9851 4.0551 1500000
KEMPHARM INC KMPH 2022-01-19 13:15:03 UTC -3.9851 4.0551 1500000
KEMPHARM INC KMPH 2022-01-19 12:45:03 UTC -3.9851 4.0551 1400000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments